Europe's pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

A new survey commissioned by Leo Pharma confirms that there’s plenty of room in the market for its chronic hand eczema ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...

Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the ...

The report also indicated that Black and Hispanic consumers are more willing to take action based on the content and ...

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

Tom Hughes is the founder and CEO of Virtual Science AI.

Despite the continued success of GLP-1 drugs Ozempic and Wegovy, Novo Nordisk CEO Lars Fruergaard Jørgensen took a slight pay cut in 2024. He received 57.1 million Danish kroner (DKK) — $8 million — ...

The wellness industry, now worth $6.8 trillion, rivals big pharma in size but faces scrutiny for being unregulated and ripe ...

Ron Lanton, Partner, Lanton Law, examines the legal and economic impacts of reciprocal tariffs on the pharma supply chain, including potential disruptions and increased drug costs.

Specifically, the likelihood that Canada’s Drug Agency would recommend that the federal government, provinces, and ...